Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathwayJibo Han, Jianjiang Xu|Drug Design Development and Therapy|2018Cited by 19
RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucomaLi Mao, Xinghuai Sun, Jianjiang Xu et al.|Diagnostic Pathology|2009Cited by 14